Data Bridge Market Research offerings new industry report "Global Radiopharmaceuticals Market" is expected to reach USD 9.49 billion by 2024 from USD 4.87 billion in 2016, at a CAGR of 8.7% in the forecast period 2017 to 2024.

Pune, India -- (SBWire) -- 01/25/2018 --Radiopharmaceuticals Market report give rising open doors in the market and the future effect of significant drivers and difficulties and, bolster leaders in settling on practical business choices. Radiopharmaceuticals are a group of pharmaceuticals drug which have radioactivity. It can be used as diagnostic and therapeutic agent. Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical area for diagnosis or therapy. The procedures and facilities for the production, use, and storage of radiopharmaceuticals are subject to licensing by national or regional authorities.

Ask for Free Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-radiopharmaceuticals-market

Major Players in Global Radiopharmaceuticals Market are included which give a brief analysis of following points:


- Market Overview

- Market Dynamics

- Drivers, Restraints, Opportunities and Challenges

- Market sizing and growth analysis

- Market forecasting to 2024

- Market Competitive Landscape

- Product Launches and Pipeline Analysis

- Value Chain Analysis

- Market Mergers, Acquisitions and Agreements

- Company Profiles


Market Segmentation:


- On the basis of type, the global radiopharmaceuticals market is sub-segmented into diagnostic and therapeutic radiopharmaceuticals. In 2017, diagnostic radiopharmaceuticals segment dominate the market and is expected to grow at the highest in the forecast period. This is due to the production of MO-99 in the U.S., FDA approvals of radiopharmaceuticals, initiatives of International Atomic Energy Agency (IAEA), new irradiation facility in Germany, installation of PET scanners in India, andgovernment investments in Rest of Asia-Pacific.


- On the basis of procedural volumes, the global radiopharmaceuticals market is sub-segmented into diagnostic procedures and therapeutic procedures. Diagnostic procedures are further sub-segmented into single-photon emission computed tomography (SPECT) radiopharmaceuticals and positron emission tomography (PET) radiopharmaceuticals. Therapeutic procedures are further sub-segmented into beta emitters, alpha emitters and brachy therapy.


- On the basis of application, the global radiopharmaceuticals market is sub-segmented into diagnostic application and therapeutic application. Diagnostic application are further sub-segmented into single-photon emission computed tomography (SPECT) and positron emission tomography (PET). Single-photon emission computed tomography (SPECT) includes cardiology, lymphoma, thyroid, neurology and others. Positron emission tomography (PET) includes oncology, cardiology, neurology and others. Therapeutic application is further sub-segmented into thyroid, bone metastasis, lymphoma, endocrine tumours and others.


- On the basis of sources, the global radiopharmaceuticals market is sub-segmented into nuclear reactors and cyclotrons.


- On the basis of end user, the global radiopharmaceuticals market is sub-segmented into hospitals, ambulatory surgical centers, diagnostic centers, cancer research institutesand others. In 2017, hospital segment dominate the market with the highest market share due to accessibility of highly skilled medical practitioners in the radiology departments of hospitals.



Request for Table of Content of Full Report @ http://databridgemarketresearch.com/toc/?dbmr=global-radiopharmaceuticals-market

Top Challengers:


- Cardinal Health Inc.

- GE Healthcare

- Lantheus Medical Imaging Inc.

- Bayer AG

- Bracco Imaging SpA

- Eczacibasi-Monrol Nuclear Products

- Nordion Inc.

- Advanced Accelerator Applications S.A.

- IBA Molecular Imaging

- CovidienPlc

- Positron Corporation

- NTP Radioisotopes Pty. Ltd.

- Actinium Pharmaceuticals Inc.,

- Among others.


Read more about Report Visit @ http://databridgemarketresearch.com/reports/global-radiopharmaceuticals-market/

Related Report

North America Digital Health Monitoring Market – Industry Trends and Forecast to 2024

North America Digital Health Monitoring Market By Product Type Devices (Blood Pressure Monitors, Blood Glucose Monitors, ECG, Oximeters, Peak Flow Monitors, Multi Parameter Monitors, Sleep Neap Monitors, Neurological Monitors, Others), Software (Healthcare Apps, Chronic Disease Apps, Personal Health Apps, Others), Services (Remote Monitoring, Consultancy Services, Treatment Services, Fitness and Wellness Services, Others), By Country (U.S., Canada, Mexico) –  Industry Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/north-america-digital-health-monitoring-devices-market/

About Data Bridge Market Research
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818

Email: Sales@databridgemarketresearch.com

Investor: investors@databridgemarketresearch.com

Visit Blog: http://databridgemarketresearch.com/blog/

Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research